CD69 and cancer: Top hits from the on-nivo tumors included features aligned with previously published findings – such as the ratio of T cells and B cells vs. cancer cells40, the expression of PD-L1 on macrophages20, and the expression of CD69 as a marker of tissue residence39 – in addition to other correlates of outcome, such as cancer cell and fibroblast diversity.